Cargando…
Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
BACKGROUND: Female BRCA1 and BRCA2 mutation carriers have an increased lifetime risk of developing breast and/or ovarian cancer. Hence, they face the difficult decision of choosing a preventive strategy such as risk-reducing surgeries or intensified breast screening. To help these women during their...
Autores principales: | Krassuski, Lisa, Vennedey, Vera, Stock, Stephanie, Kautz-Freimuth, Sibylle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670224/ https://www.ncbi.nlm.nih.gov/pubmed/31370837 http://dx.doi.org/10.1186/s12911-019-0872-2 |
Ejemplares similares
-
Decision Aids for Preventive Treatment Alternatives for
BRCA1/2
Mutation Carriers: a Systematic Review
por: Krassuski, Lisa Marlene, et al.
Publicado: (2021) -
Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2021) -
Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2022) -
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2023) -
Decision aids for female BRCA mutation carriers: a scoping review protocol
por: McGarrigle, Sarah A, et al.
Publicado: (2021)